Avadel Pharmaceuticals (AVDL) PT Lowered to $10 at Ladenburg Thalmann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Laidlaw Downgrades Avadel Pharmaceuticals (AVDL) to Neutral
November 6, 2018 8:58 AM ESTLaidlaw analyst Francois Brisebois downgraded Avadel Pharmaceuticals (NASDAQ: AVDL) from Buy to Neutral with a price target of $5.50 (from $11.00).
For an analyst ratings summary and ratings history on Avadel Pharmaceuticals click here. For more ratings news on Avadel Pharmaceuticals click here.
Shares of Avadel Pharmaceuticals closed at $3.06 yesterday.
... MoreAvadel Pharmaceuticals (AVDL) PT Lowered to $3 at SunTrust Robinson Humphrey
November 6, 2018 3:43 AM ESTSunTrust Robinson Humphrey analyst John Boris lowered the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $3.00 (from $7.00) while maintaining a Hold rating.
... More